7 February 2018 - PHARMAC is rejecting any suggestion it reacted to political pressure to fund a new anti-HIV drug.
The drug-buying agency has announced that from next month it will expand access to a treatment using Truvada.
The drug is already funded as part of a treatment for those infected with HIV but will now also be free for those not infected but at high risk of contracting the virus.